KROS vs XEL · rev $32.0K vs P/E 20, $39.33B cap
Keros Therapeutics Inc (KROS) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported KROS revenue for 2026-06-30 was $32.0K. Net income was -$52.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. KROS currently screens at market cap $208.8M.
XEL does not have a complete income-statement cache yet.
KROS currently screens at market cap $208.8M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the KROS and XEL stock pages for the full models.
Not investment advice.